Abstract
Coccidioidomycosis is an endemic systemic mycosis of the western hemisphere that has acquired mayor relevance after a raise in cases in the recent years. Two species, Coccidioides immitis and C. posadasii are recognized as the causative agents of this disease that, in principle, primarily affects the lungs. Extra pulmonary cutaneous forms have been more frequently reported and its manifestations present a vast clinical spectrum that resembles subcutaneous mycosis, cutaneous tuberculosis or even skin cancer. The interaction of the host and its immune response against the fungus and its pathogenic mechanism play a major role in the evolution, clinical and histopathological aspects and finally in the resolution of the disease.
Similar content being viewed by others
References
Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
Colombo AL, Tobón A, Restrepo A, et al. Epidemiology of endemic systemic fungal infections in Latin America. Med Mycol. 2011;49(8):785–98.
Benedict K, Thompson III GR, Deresinski S, Chiller T. Mycotic infections acquired outside areas of known endemicity. United States Emerg Infect Dis. 2015;21(11):1935–41. doi:10.3201/eid2111.141950.
Blair J, Chang YH, Cheng MR, et al. Characteristics of patients with mild to moderate primary pulmonary coccidioidomycosis. Emerg Infect Dis. 2014;20(6):983–90. doi:10.3201/eid2006.131842. Prospective study and detail description of patients with pulmonary coccidioidomycosis.
Chang A, Tung RC, McGillis TS, et al. Primary cutaneous coccidioidomycosis. J Am Acad Dermatol. 2003;49(5):944–9.
Blair JE. State-of-the-art treatment of coccidioidomycosis skin and soft-tissue infections. Ann NY Acad Sci. 2007;1111:411–21.
Sondermeyer G, Lee L, Gilliss D, et al. Associated-associated hospitalizations, California, USA, 2000–2011. Emerg Infect Dis. 2013;19(10):1590–7. doi:10.3201/eid1910.130427.
CDC. Increase in reported coccidioidomycosis—United States, 1998–2011. MMWR. 2013;62(12):217–21. Epidemiology report of coccidiodomycosis cases have increased dramatically in endemic areas.
Seitz AE, Prevots DR, Holland SM. Hospitalizations associated with disseminated coccidioidomycosis, Arizona and California, USA. Emerg Infect Dis. 2012;18(9):1476–9. doi:10.3201/eid1809.120151.
Crum NF, Ballon-Landa G. Coccidioidomycosis in pregnancy: case report and review of the literature. Am J Med. 2006;119(11):993. e11-7.
Marsden-Haug N, Goldoft M, Ralston C, et al. Coccidioidomycosis acquired in Washington State. Clin Infect Dis. 2013;56(6):847–50. doi:10.1093/cid/cis1028.
Litvintseva AP, Marsden-Haug N, Hurst S, et al. Valley fever: Finding new places for an old disease: Coccidioides immitis found in Washington state soil associated with recent human infection. Clin Infect Dis. 2015;60(1):e1–3. doi:10.1093/cid/ciu681. This study demonstrates colonization of soils by C. immitis linked to human infections and located outside the endemic range.
Wilson JW. The importance of portal of entry in certain microbial infections. The primary cutaneous “chancriform syndrome”. Dis Chest; 54(S1): 299–304. http://journal.publications.chestnet.org.
Deus Filho A, Deus ACB, Meneses AO, et al. Skin and mucous membrane manifestations of coccidioidomycosis: a study of thirty cases in the Brazilian states of Piauí and Maranhão. An Bras Dermatol. 2010;85(1):45–51. doi:10.1590/S0365-05962010000100006.
Simental-Lara F, Bonifaz A. Coccidioidomicosis en la región lagunera de Coahuila, México. Dermatol Rev Mex. 2011;55(3):140–51.
Moreno-Coutiño G, Arce-Ramírez M, Medina A, et al. Coccidioidomicosis cutánea. Comunicación de seis casos mexicanos. Rev Chilena Infectol. 2015;32(3):339–43. This article is one of first reports of Coccidioides posadasii infection in cutaneous coccidioidomycosis.
Salas-Alanis JC, Ocampo-Candiani J, Cepeda-Valdes R, et al. Cutaneous coccidioidomycosis: Incidental finding. J Clin Exp Dermatol Res. 2012;3:147. doi:10.4172/2155-9554.1000147.
Narang V, Garg B, Sood N, Goraya SK. Primary cutaneous coccidioidomycosis: first imported case in north India. Indian J Dermatol. 2014;59:422.
Kantarcioglu AS, Sandoval-Denis M, Aygun G, et al. First imported coccidiodomycosis in Turkey: a potential health risk for laboratory workers outside endemic areas. Med Mycol Case Rep. 2014;3:20–5. doi:10.1016/j.mmcr.2014.01.002.
Al-Daraji WI, Al-Mahmoud RM, Ali MA. Disseminated Coccidioidomycosis: a case report from the United Kingdom. Int J Clin Exp Pathol. 2009;2:494–7. www.ijcep.com/IJCEP803007.
Tortorano AM, Carminati G, Tosoni A, et al. Primary cutaneous coccidioidomycosis in an Italian nun working in South America and review of published literature. Mycopathologia. 2015;180(3-4):229–35. doi:10.1007/s11046-015-9895-0.
Whiston E, Taylor JW. Comparative phylogenomics of pathogenic and nonpathogenic species. G3: Genes Genomes Genetics. 2016;6(2):235–44. doi:10.1534/g3.115.022806. Phylogenetic study on Coccidioides spp. gene family expansion/contraction and their metabolism.
Nguyen C, Barker BM, Hoover S, et al. Recent advances in our understanding of the environmental, epidemiological, immunological, and clinical dimensions of coccidioidomycosis. Clin Microbiol Rev. 2013;26(3):505–25. doi:10.1128/CMR.00005-13. This is a complete review of the disease.
Gaidici A, Saubolle MA. Transmission of coccidioidomycosis to a human via a cat bite. J Clin Microbiol. 2009;47(2):505–6. doi:10.1128/JCM.0186008.
Johnson L, Gaab EM, Sanchez J, et al. Valley fever: danger lurking in a dust cloud. Microbes Infect. 2014;16(8):591–600. doi:10.1016/j.micinf.2014.06.011. This is a review comprehending pathogenic aspects and host immune response.
Lewis ERG, Bowers JR, Barker BM. Dust devil: the life and times of the fungus that causes valley fever. PLoS Pathog. 2015;11(5):e1004762. doi:10.1371/journal.ppat.1004762.
Vinh DC, Schwartz B, Hsu AP, et al. Interleukin-12 receptor b1 deficiency predisposing to disseminated coccidioidomycosis. Clin Infect Dis. 2011;52(4):e99–102.
Hung C-Y, Seshan K, Yu J, et al. A metalloproteinase of Coccidioides posadasii contributes to evasion of host detection. Infect Immune. 2005;73(10):6689–703.
Fanning S, Mitchell AP. Fungal biofilms. PLoS Pathog. 2012;8(4):e1002585. doi:10.1371/journal.ppat.1002585.
Sharpton TJ, Stajich JE, Rounsley SD, et al. Comparative genomic analyses of the human fungal pathogens Coccidioides and their relatives. Genome Res. 2009;19:1722–31.
Li J, Yu L, Tian Y, Zhang KQ. Molecular evolution of the deuterolysin (M35) family genes in Coccidioides. PLoS One. 2012;7(2):e31536. doi:10.1371/journal.pone.0031536.
Mirbod-Donovan F, Schaller R, Hung C-Y, et al. Urease produced by Coccidioides posadasii contributes to the virulence of this respiratory pathogen. Infect Immun. 2006;74(1):504–15. doi:10.1128/IAI.74.1.504-515.2006.
Wise HZ, Hung C-Y, Whiston E, Taylor JW, Cole GT. Extracellular ammonia at sites of pulmonary infection with Coccidioides posadasii contributes to severity of the respiratory disease. Microb Pathog. 2013;0:19–28. doi:10.1016/j.micpath.2013.04.003.
Ondo AL, Zlotoff J, Mings SM, et al. Primary cutaneous coccidioidomycosis: an incidental finding. Clin Exp Dermatol. 2010;35(3):e42–3.
DiCaudo DJ. Coccidioidomycosis: a review and update. J Am Acad Dermatol. 2006;55(6):929–42.
DiCaudo DJ. Coccidioidomycosis. Semin Cutan Med Surg. 2014;33:140–5.
Garcia-Garcia SC, Salas-Alanis JC, Gomez-Flores M, et al. Coccidioidomycosis and the skin: a comprehensive review. An Bras Dermatol. 2015;90(5):610–21. doi:10.1590/abd1806-4841.20153805.
Mangold AR, DiCaudo DJ, Blair JE, Sekulic A. Chronic interstitial granulomatous dermatitis in coccidioidomycosis. Br J Dermatol. 2015; 17. doi: 10.1111/bjd.14295
Garza-Chapa JI, Martínez-Cabriales SA, Ocampo-Garza J, et al. Cold subcutaneous abscesses as the first manifestation of disseminated coccidioidomycosis in an immunocompromised host. Australas J Dermatol. 2015. doi:10.1111/ajd.12424.
Langelier C, Baxi SM, Iribarne D, Chin-Hong P. Beyond the superficial: Coccidioides immitis fungaemia in a man with fever, fatigue and skin nodules: a case of an emerging and evolving pathogen. BMJ Case Reports. 2014. doi:10.1136/bcr-2014-205333.
Carpenter JB, Feldman JS, Leyva WH, et al. Clinical and pathologic characteristics of disseminated cutaneous coccidioidomycosis. J Am Acad Dermatol. 2010;62(5):831–7.
Ocampo-Garza J, Castrejón-Pérez AD, Gonzalez-Saldivar G, et al. Cutaneous coccidioidomycosis: a great mimicker. BMJ Case Rep. 2015. doi:10.1136/bcr-2015-211680.
Rodriguez R, Konia T. Coccidioidomycosis of the tongue. Arch Pathol Lab Med. 2005;129(1):e4–6.
Ellerbrook L, Laks S, Cocciodioidomycosis osteomyelitis of the knee in a 23-year-old diabetic patient. Radiol Case Reports. (Online) 2014; 10(1); 1034.
Jaramillo-Moreno G, Velázquez-Arenas L, Mendez-Olvera N, Ocampo-Candiani J. Primary cutaneous coccidioidomycosis: case report and review of the literature. Int J Dermatol. 2006;45:121–3. doi:10.1111/j.1365-4632.2004.02446.x.
Rojas-García OC, Moreno-Treviño MG, González-Salazar F, et al. Primary cutaneous coccidioidomycosis in an infant. Gac Med Mex. 2014;150(2):175–6.
Saúl A, Bonifaz A. Clasificación de la esporotricosis. Una propuesta con base en el comportamiento inmunológico. Dermatol Rev Mex. 2011;55(4):200–8.
Tchernev G, Cardoso JC, Chokoeva AA, et al. The “mystery” of cutaneous sarcoidosis: facts and controversies. Int J Immunopathol Pharmacol. 2014;27(3):321–30.
Newlon HR, Lambiase MC. Disseminated cutaneous coccidioidomycosis masquerading as lupus pernio. Cutis. 2010;86(1):25–8.
Crum NF. Disseminated coccidioidomycosis with cutaneous lesions clinically mimicking mycosis fungoides. Int J Dermatol. 2005;44(11):958–60.
Arora NP, Taneja V, Reyes Sacin C, et al. Coccidioidomycosis masquerading as malignancy. BMJ Case Rep. 2012. doi:10.1136/bcr.12.2011.5357.
Wilson JW, Smith CE, Plunkett OA. Primary cutaneous coccidioidomycosis. The criteria for diagnosis and a report of a Case. Calif Med. 1953;79(3):233–9. PMCID: PMC1521839.
Pappagianis D. The phenomenon of locus minoris resistentiae in coccidioidomycosis. In: Coccidioidomycosis, Proceedings of the 4th International Conference on Coccidioidomycosis, San Diego, Calif. March, 14-17, 1984. Washington, DC: The National Foundation for Infectious Diseases; 1985:319–329.
Ruocco V, Brunetti G, Puca RV, Ruocco E. The immunocompromised district: a unifying concept for lymphoedematous, herpes-infected and otherwise damaged sites. J Eur Acad Dermatol Venereol. 2009;23(12):1364–73. doi:10.1111/j.1468-3083.2009.03345.x.
Ruocco V, Ruocco E, Piccolo V, et al. The immunocompromised district in dermatology: a unifying pathogenic view of the regional immune dysregulation. Clin Dermatol. 2014;32(5):569–76. doi:10.1016/j.clindermatol.2014.04.004.
Muñoz-Hernández B, Palma-Cortés G, Carlos Cabello-Gutiérrez C, et al. Parasitic polymorphism of Coccidioides spp. BMC Infect Dis. 2014;14:213. http://www.biomedcentral.com/1471-2334/14/213 . In this study, the authors observed parasitic morphological diversity of Coccidioides in clinical samples.
Kappel ST, Wu JJ, Hillman JD, et al. Histopathologic findings of disseminated coccidioidomycosis with hyphae. Arch Dermatol. 2007;143(4):548–9. doi:10.1001/archderm.143.4.548.
Ampel NM. The diagnosis of coccidioidomycosis. F1000 Med Rep. 2010;2:2. doi:10.3410/M2-2.
Berg N, Ryscavage P, Kulesza P. The utility of fine needle aspiration for diagnosis of extrapulmonary coccidioidomycosis: a case report and discussion. Clin Med Res. 2011;9(3-4):130–3.
Aly FZ, Millis R, Sobonya R, et al. Cytologic diagnosis of coccidiodomycosis: spectrum of findings in Southern Arizona patients over a 10 year period. Diagn Cytopathol. 2016;44(3):195–200. doi:10.1002/dc.23419.
Khalbuss WE, Michelow P, Benedict C, et al. Cytomorphology of unusual infectious entities in the Pap test. Cyto J. 2012;9:15. doi:10.4103/1742-6413.97763.
Guarner J, Brandt ME. Histopathologic diagnosis of fungal infections in the 21st century. Clin Microbiol Rev. 2011;24(2):247–80. doi:10.1128/CMR.00053-10.
Fernandez-Flores A, Saeb-Lima M, Arenas-Guzman R. Morphological findings of deep cutaneous fungal infections. Am J Dermatopathol. 2014;36(7):531–56.
Jehangir W, Tadepalli GS, Sen S, et al. Coccidioidomycosis and blastomycosis: endemic mycotic co-infections in the HIV patient. J Clin Med Res. 2015;7(3):196–8. doi:10.14740/jocmr2036w.
Miller JM, Astles R, Baszler T, et al. Guidelines for safe work practices in human and animal medical diagnostic laboratories. Recommendations of a CDC-convened, Biosafety Blue Ribbon Panel. MMWR. 2012;61(1):1–102.
Johnson R, Kernerman SM, Sawtelle BG, et al. Reformulated spherule-derived coccidioidin (Spherusol) to detect delayed-type hypersensitivity in coccidioidomycosis. Mycopathologia. 2012;174(5-6):353–8. doi:10.1007/s11046-012-9555-6.
Wack EE, Ampel NM, Sunenshine RH, Galgiani JN. The return of delayed-type hypersensitivity skin testing for coccidioidomycosis. Clin Infect Dis. 2015;61(5):787–91. doi:10.1093/cid/civ388.
Mendoza N, Blair JE. The utility of diagnostic testing for active coccidioidomycosis in solid organ transplant recipients. Am J Transplant. 2013;13(4):1034–9. doi:10.1111/ajt.12144.
Arvanitis M, Anagnostou T, Fuchs BB, et al. Molecular and nonmolecular diagnostic methods for invasive fungal infections. Clin Microbiol Rev. 2014;27(3):490–526. doi:10.1128/CMR.00091-13.
Navalkar KA, Johnston SA, Woodbury N, et al. Application of immunosignatures for diagnosis of valley fever. Clin Vaccine Immunol. 2014;21(8):1169–77. doi:10.1128/CVI.00228-14. This is a new technology improve Coccidioidomycosis diagnosis with a higher sensitivity and it can distinguish related infections.
Duarte-Escalante E, Frias-De leon MG, et al. Molecular markers in the epidemiology and diagnosis of coccidioidomycosis. Rev Iberoam Micol. 2014;31(1):49–53.
Binnicker MJ, Buckwalter SP, Eisberner JJ, et al. Detection of Coccidioides species in clinical specimens by real-time PCR. J Clin Microbiol. 2007;45(1):173–8. doi:10.1128/JCM.01776-06.
Mitchell M, Dizon D, Libke R, et al. Development of a real-time PCR assay for identification of Coccidioides immitis by use of the BD Max system. J Clin Microbiol. 2015;53(3):926–9. doi:10.1128/JCM.02731-14.
Ampel NM. The treatment of coccidioidomycosis. Rev Inst Med Trop Sao Paulo. 2015;57(S19):51–6. doi:10.1590/S0036-46652015000700010.
Welsh O, Vera-Cabrera L, et al. Coccidioidomycosis. Clin Dermatol. 2012;30(6):573–91.
Bercovitch RS, Catanzaro A, Schwartz BS, et al. Coccidioidomycosis during pregnancy: a review and recommendations for management. Clin Infect Dis. 2011;53(4):363–8. doi:10.1093/cid/cir410.
Catanzaro A, Cloud GA, Stevens DA, et al. Safety, tolerance, and efficacy of posaconazole therapy in patients with nonmeningeal disseminated or chronic pulmonary coccidioidomycosis. Clin Infect Dis. 2007;45(5):562–8.
Chang M, Chagan L. Posaconazole (Noxafil), an extended-spectrum oral triazole antifungal agent. Pharm Ther. 2008;33(7):391–426. PMC2740948.
Lat A, Thompson III GR. Update on the optimal use of voriconazole for invasive fungal infections. Infect Drug Resist. 2011;4:43–53. doi:10.2147/IDR.S12714.
Kim MM, Vikram HR, Kusne S, et al. Treatment of refractory coccidioidomycosis with voriconazole or posaconazole. Clin Infect Dis. 2011;53(11):1060–6. doi:10.1093/cid/cir642.
Duplessis CA, Tilley D, Bavaro M, et al. Two cases illustrating successful adjunctive interferon-g immunotherapy in refractory disseminated coccidioidomycosis. J Infect. 2011;63(3):223–8. doi:10.1016/j.jinf.2011.07.006.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
Martin Arce and Daniela Gutierrez-Mendoza declare that we have no conflicts of interests.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
Additional information
This article is part of the Topical Collection on Fungal Infections of Skin and Subcutaneous Tissue
Rights and permissions
About this article
Cite this article
Arce, M., Gutierrez-Mendoza, D. Primary and Disseminated Cutaneous Coccidioidomycosis: Clinical Aspects and Diagnosis. Curr Fungal Infect Rep 10, 132–139 (2016). https://doi.org/10.1007/s12281-016-0263-4
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12281-016-0263-4